Fortress Biotech, Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -59.5% | -42.7% | -16.3% |
| FY2022 | -207.5% | -64.9% | -29.4% |
| FY2023 | -269.0% | -72.7% | -36.2% |
| FY2024 | -202.3% | -57.0% | -31.9% |
| FY2025 | 13.7% | 6.7% | 3.7% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -59.5% | -42.7% | -16.3% |
| FY2022 | -207.5% | -64.9% | -29.4% |
| FY2023 | -269.0% | -72.7% | -36.2% |
| FY2024 | -202.3% | -57.0% | -31.9% |
| FY2025 | 13.7% | 6.7% | 3.7% |